Home LiteratureArticle Details
PMID: 7890324 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

MHC ligands and peptide motifs: first listing.

Immunogenetics ·Vol. 41 ·No. 4 ·1995-00-00 ·Pages 178-228

Rammensee HG, Friede T, Stevanoviíc S

Abstract

暂无摘要

MeSH Terms
Amino Acid Sequence Animals Humans Ligands Major Histocompatibility Complex/genetics Molecular Sequence Data Peptides/chemistry,metabolism Protein Binding Sequence Analysis Sequence Homology, Amino Acid
Chemicals
Ligands Peptides
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rammensee H G
Abteilung Tumorvirus-Immunologie (0620), Deutsches Krebsforschungszentrum, Heidelberg, Germany.
Friede T
Stevanoviíc S
References (222)
222 references, click to expand
  1. Mouse H-2k-restricted cytotoxic T cells recognize antigenic determinants in both the HA1 and HA2 subunits of the influenza A/PR/8/34 hemagglutinin.
    J Exp Med. 1987 Sep 1;166(3):693-701 PMID: 2442286
  2. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.
    J Immunol. 1993 Jan 15;150(2):499-507 PMID: 8419482
  3. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays.
    Mol Immunol. 1994 Aug;31(11):813-22 PMID: 8047072
  4. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle.
    Nature. 1992 Nov 26;360(6402):364-6 PMID: 1448153
  5. Strong conformational propensities enhance T cell antigenicity.
    J Immunol. 1987 Jan 1;138(1):204-12 PMID: 2431054
  6. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity.
    J Virol. 1989 Oct;63(10):4303-10 PMID: 2476570
  7. Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.
    J Exp Med. 1992 Dec 1;176(6):1681-92 PMID: 1281216
  8. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
    J Exp Med. 1994 Jul 1;180(1):35-42 PMID: 8006593
  9. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective.
    Cell. 1993 Aug 13;74(3):577-84 PMID: 8348620
  10. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.
    Proc Natl Acad Sci U S A. 1990 Mar;87(6):2344-8 PMID: 1690429
  11. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
    J Exp Med. 1994 Jan 1;179(1):279-90 PMID: 7505801
  12. Maternally transmitted antigen of mice: a model transplantation antigen.
    Annu Rev Immunol. 1991;9:351-72 PMID: 1910682
  13. Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide.
    Eur J Immunol. 1991 May;21(5):1181-5 PMID: 1709866
  14. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides.
    J Immunol. 1994 Apr 15;152(8):3884-94 PMID: 8144958
  15. A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes.
    J Exp Med. 1989 Sep 1;170(3):1051-6 PMID: 2475569
  16. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.
    J Immunol. 1993 Oct 15;151(8):3971-80 PMID: 7691936
  17. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
    J Exp Med. 1992 Nov 1;176(5):1453-7 PMID: 1402688
  18. An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia.
    Eur J Immunol. 1994 Sep;24(9):2203-12 PMID: 8088336
  19. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules.
    Eur J Immunol. 1991 Sep;21(9):2069-75 PMID: 1889458
  20. Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions.
    J Virol. 1992 Oct;66(10):5967-74 PMID: 1382144
  21. A subset of HLA-B27 molecules contains peptides much longer than nonamers.
    Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1534-8 PMID: 8108441
  22. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
    Nature. 1993 Jul 1;364(6432):33-9 PMID: 8316295
  23. Source of unique tumour antigens.
    Nature. 1994 Oct 20;371(6499):662 PMID: 7935811
  24. Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide.
    J Exp Med. 1990 Jul 1;172(1):35-45 PMID: 1694221
  25. Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.
    Immunogenetics. 1994;40(4):306-8 PMID: 7521860
  26. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.
    J Immunol. 1991 Oct 15;147(8):2663-9 PMID: 1717570
  27. Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins.
    J Gen Virol. 1994 Mar;75 ( Pt 3):589-96 PMID: 7510328
  28. Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif.
    Immunology. 1994 Feb;81(2):222-7 PMID: 8157270
  29. Sequence features that correlate with MHC restriction.
    Mol Immunol. 1994 Jan;31(1):1-19 PMID: 8302295
  30. H-2Kd-restricted antigenic peptides share a simple binding motif.
    J Exp Med. 1991 Sep 1;174(3):603-12 PMID: 1714934
  31. Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin.
    J Virol. 1991 Oct;65(10):5401-9 PMID: 1716691
  32. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.
    Nature. 1989 Sep 28;341(6240):323-6 PMID: 2477703
  33. Comparison of peptides bound to spleen and thymus class II.
    J Exp Med. 1993 Dec 1;178(6):2173-83 PMID: 8245790
  34. Sequence analysis of peptides bound to MHC class II molecules.
    Nature. 1991 Oct 17;353(6345):622-7 PMID: 1656276
  35. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
    J Exp Med. 1993 Jul 1;178(1):27-47 PMID: 8315383
  36. Measles virus hemagglutinin induces an Ld-restricted CD8+ cytotoxic T lymphocyte response to two specific epitopes.
    Virology. 1994 Apr;200(1):281-3 PMID: 7510439
  37. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2.
    J Immunol. 1991 Dec 15;147(12):4047-53 PMID: 1721637
  38. Sequence of a prominent 16-residue self-peptide bound to HLA-B27 in a lymphoblastoid cell line.
    Cell Immunol. 1993 Dec;152(2):623-6 PMID: 8258157
  39. Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules.
    Immunogenetics. 1994;40(3):238-41 PMID: 8039832
  40. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone.
    J Virol. 1993 Jan;67(1):438-45 PMID: 7677956
  41. Interaction of MHC class I molecules with the transporter associated with antigen processing.
    Science. 1994 May 27;264(5163):1322-6 PMID: 8191286
  42. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.
    Science. 1987 Mar 13;235(4794):1353-8 PMID: 2435001
  43. H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide.
    Nature. 1986 Dec 11-17;324(6097):578-9 PMID: 3491326
  44. Identification of self peptides bound to purified HLA-B27.
    Nature. 1991 Sep 26;353(6342):326-9 PMID: 1922338
  45. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
    Science. 1991 Dec 13;254(5038):1643-7 PMID: 1840703
  46. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
    J Virol. 1993 Mar;67(3):1572-8 PMID: 7679748
  47. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain.
    Tissue Antigens. 1994 Nov;44(5):311-7 PMID: 7878657
  48. Thymic selection: a matter of life and death.
    Immunol Today. 1992 Nov;13(11):454-8 PMID: 1476601
  49. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    J Exp Med. 1992 Jul 1;176(1):169-76 PMID: 1377222
  50. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    J Immunol. 1993 May 15;150(10):4659-71 PMID: 7683326
  51. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides.
    J Immunol. 1992 Nov 1;149(9):2864-71 PMID: 1383331
  52. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.
    Nature. 1991 Dec 12;354(6353):453-9 PMID: 1721107
  53. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
    J Immunol. 1993 Dec 1;151(11):5930-5 PMID: 7504010
  54. Consensus motifs and peptide ligands of MHC class I molecules.
    Semin Immunol. 1993 Apr;5(2):81-94 PMID: 7684938
  55. Cells infected with Yersinia present an epitope to class I MHC-restricted CTL.
    J Immunol. 1994 Aug 15;153(4):1603-12 PMID: 8046234
  56. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
    Eur J Immunol. 1993 Feb;23(2):447-53 PMID: 7679646
  57. Association of class I major histocompatibility heavy and light chains induced by viral peptides.
    Nature. 1989 Aug 10;340(6233):443-8 PMID: 2666863
  58. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes.
    Nature. 1989 Feb 16;337(6208):651-3 PMID: 2465495
  59. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.
    J Immunol. 1993 Sep 15;151(6):3163-70 PMID: 7690794
  60. Cloning and sequence of the gene for heat shock protein 60 from Chlamydia trachomatis and immunological reactivity of the protein.
    Infect Immun. 1991 Jan;59(1):79-90 PMID: 1987066
  61. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
    Cell. 1986 Mar 28;44(6):959-68 PMID: 2420472
  62. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope.
    J Immunol. 1994 Jan 15;152(2):686-94 PMID: 7506732
  63. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9514-8 PMID: 2480604
  64. On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes.
    J Exp Med. 1987 Sep 1;166(3):678-92 PMID: 2442285
  65. Peptide motifs of HLA-B58, B60, B61, and B62 molecules.
    Immunogenetics. 1995;41(2-3):165-8 PMID: 7806292
  66. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3515-9 PMID: 8170938
  67. Tum- mutation P35B generates the MHC-binding site of a new antigenic peptide.
    Immunogenetics. 1993;37(2):135-8 PMID: 8423052
  68. Structure of peptides associated with MHC class I molecules.
    Curr Opin Immunol. 1994 Feb;6(1):13-23 PMID: 7513522
  69. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease.
    Int Immunol. 1995 Feb;7(2):223-8 PMID: 7734418
  70. Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.
    Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8053-7 PMID: 8367462
  71. Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes.
    J Exp Med. 1994 Jan 1;179(1):195-202 PMID: 7505798
  72. Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region.
    Eur J Immunol. 1986 Nov;16(11):1379-84 PMID: 3096741
  73. Cell biology of antigen presentation.
    Curr Opin Immunol. 1993 Feb;5(1):27-34 PMID: 7680870
  74. Heat shock proteins transfer peptides during antigen processing and CTL priming.
    Immunogenetics. 1994;39(2):93-8 PMID: 8276462
  75. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs.
    J Immunol. 1993 Dec 1;151(11):5966-74 PMID: 8245441
  76. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.
    J Virol. 1993 Feb;67(2):694-702 PMID: 7678303
  77. Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells.
    Nature. 1989 Nov 9;342(6246):180-2 PMID: 2478887
  78. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.
    J Exp Med. 1991 Aug 1;174(2):425-34 PMID: 1713253
  79. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.
    Cell. 1994 Sep 9;78(5):761-71 PMID: 8087844
  80. Fine mapping of an H-2Kk restricted cytotoxic T lymphocyte epitope in SV40 T antigen by using in-frame deletion mutants and a synthetic peptide.
    J Immunol. 1988 Oct 15;141(8):2734-9 PMID: 2459227
  81. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.
    J Virol. 1992 Apr;66(4):2527-31 PMID: 1372370
  82. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    J Immunol. 1994 Aug 15;153(4):1665-73 PMID: 7519208
  83. Origin, structure and motifs of naturally processed MHC class II ligands.
    Curr Opin Immunol. 1994 Feb;6(1):45-51 PMID: 7513525
  84. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
    Eur J Immunol. 1993 Nov;23(11):2777-81 PMID: 7693478
  85. Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein.
    J Virol. 1993 Apr;67(4):2276-84 PMID: 7680390
  86. Specialized functions of major histocompatibility complex class I molecules. II. Hmt binds N-formylated peptides of mitochondrial and prokaryotic origin.
    J Exp Med. 1991 Oct 1;174(4):941-4 PMID: 1919442
  87. HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.
    Proc Natl Acad Sci U S A. 1990 Sep;87(18):7045-9 PMID: 1698289
  88. Mass spectrometric analysis of peptides associated with the human class I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding.
    Chem Immunol. 1993;57:39-62 PMID: 8260089
  89. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.
    J Exp Med. 1994 Dec 1;180(6):2353-8 PMID: 7964508
  90. Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein.
    Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10277-81 PMID: 1719555
  91. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.
    Proc Natl Acad Sci U S A. 1989 May;86(9):3296-300 PMID: 2717617
  92. Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules.
    Nature. 1993 Feb 18;361(6413):642-4 PMID: 8437623
  93. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
    J Exp Med. 1993 Aug 1;178(2):489-95 PMID: 8340755
  94. A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides.
    J Exp Med. 1994 Feb 1;179(2):579-88 PMID: 8294869
  95. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.
    J Virol. 1993 Apr;67(4):2376-80 PMID: 7680391
  96. Peptide motifs of closely related HLA class I molecules encompass substantial differences.
    Eur J Immunol. 1992 Sep;22(9):2453-6 PMID: 1516632
  97. Allele-specific peptide ligand motifs of HLA-C molecules.
    Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12005-9 PMID: 8265661
  98. Antigenic peptide binding by class I and class II histocompatibility proteins.
    Structure. 1994 Apr 15;2(4):245-51 PMID: 8087551
  99. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.
    Science. 1992 Jun 26;256(5065):1817-20 PMID: 1319610
  100. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.
    Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6458-62 PMID: 8022805
  101. Precise prediction of a Kk-restricted cytotoxic T cell epitope in the NS1 protein of influenza virus using an MHC allele-specific motif.
    Virology. 1993 Mar;193(1):289-95 PMID: 7679858
  102. An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes.
    J Virol. 1994 Feb;68(2):897-904 PMID: 8289392
  103. Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
    Cell. 1993 Jul 16;74(1):197-203 PMID: 8334703
  104. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.
    Immunogenetics. 1994;39(1):74-7 PMID: 8225441
  105. Peptide selection by MHC-encoded TAP transporters.
    Curr Opin Immunol. 1994 Feb;6(1):32-7 PMID: 8172678
  106. Cytotoxic T-cell epitopes in HIV/SIV infection.
    AIDS. 1993;7 Suppl 1:S117-26 PMID: 7689848
  107. A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide.
    Science. 1988 Oct 14;242(4876):259-61 PMID: 2459778
  108. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
    J Exp Med. 1988 Jun 1;167(6):1767-79 PMID: 2455012
  109. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides.
    Nature. 1992 Apr 2;356(6368):443-6 PMID: 1557127
  110. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule.
    Nature. 1990 Nov 15;348(6298):213-6 PMID: 1700303
  111. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif.
    J Exp Med. 1992 Jun 1;175(6):1799-803 PMID: 1375272
  112. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant.
    Science. 1992 Dec 11;258(5089):1801-4 PMID: 1465617
  113. A prominent natural H-2 Kd ligand is derived from protein tyrosine kinase JAK1.
    Immunol Lett. 1993 Mar;35(3):235-7 PMID: 8514334
  114. An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.
    Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2217-21 PMID: 8384718
  115. Identification of an immunodominant epitope within the phosphoprotein of rabies virus that is recognized by both class I- and class II-restricted T cells.
    J Virol. 1991 Nov;65(11):5673-9 PMID: 1717708
  116. Antigen processing. Peptides and the proteasome.
    Nature. 1993 Sep 16;365(6443):211-2 PMID: 8371776
  117. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10275-9 PMID: 7694286
  118. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.
    J Exp Med. 1994 Sep 1;180(3):873-83 PMID: 8064238
  119. Peptide motifs of HLA-DR4/DR53 (DRB1*0405/DRB4*0101) molecules.
    Immunogenetics. 1994;40(5):376-8 PMID: 7927542
  120. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes.
    Eur J Immunol. 1994 Mar;24(3):759-64 PMID: 8125142
  121. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.
    Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8403-7 PMID: 1325657
  122. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells.
    Eur J Immunol. 1993 Sep;23(9):2242-9 PMID: 7690326
  123. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site.
    J Exp Med. 1988 Dec 1;168(6):2045-57 PMID: 3264322
  124. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag.
    J Virol. 1991 Aug;65(8):4051-6 PMID: 1712857
  125. Interaction of in vitro- and in vivo-generated cytotoxic T cells with SV40 T antigen: analysis with synthetic peptides.
    Scand J Immunol. 1994 May;39(5):467-79 PMID: 8191222
  126. Definition of specific peptide motifs for four major HLA-A alleles.
    J Immunol. 1994 Apr 15;152(8):3913-24 PMID: 8144960
  127. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
    J Immunol. 1989 Dec 15;143(12):4098-103 PMID: 2480387
  128. Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants.
    J Virol. 1990 Mar;64(3):1192-200 PMID: 1689391
  129. Exact prediction of a natural T cell epitope.
    Eur J Immunol. 1991 Nov;21(11):2891-4 PMID: 1718764
  130. Peptide motifs of HLA-B38 and B39 molecules.
    Immunogenetics. 1995;41(2-3):162-4 PMID: 7806291
  131. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis.
    J Immunol. 1992 Nov 15;149(10):3339-44 PMID: 1385523
  132. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules.
    Immunogenetics. 1994;39(4):230-42 PMID: 8119729
  133. Comparative analysis of core amino acid residues of H-2D(b)-restricted cytotoxic T-lymphocyte recognition epitopes in simian virus 40 T antigen.
    J Virol. 1992 Jan;66(1):440-7 PMID: 1370091
  134. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.
    Science. 1992 Aug 14;257(5072):919-27 PMID: 1323877
  135. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
    J Exp Med. 1994 Mar 1;179(3):921-30 PMID: 8113684
  136. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.
    J Immunol. 1994 Mar 15;152(6):2890-8 PMID: 8144889
  137. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
    J Exp Med. 1993 Mar 1;177(3):751-62 PMID: 7679709
  138. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.
    Nature. 1987 Oct 15-21;329(6140):599-604 PMID: 3309680
  139. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis.
    J Exp Med. 1991 Jan 1;173(1):19-24 PMID: 1702137
  140. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.
    J Immunol. 1993 Jan 15;150(2):438-46 PMID: 8419476
  141. Peptide motifs of HLA-B35 and -B37 molecules.
    Immunogenetics. 1993;38(2):161-2 PMID: 8482580
  142. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.
    J Virol. 1993 Dec;67(12):7428-35 PMID: 7693972
  143. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.
    Nature. 1990 Nov 15;348(6298):252-4 PMID: 1700304
  144. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum.
    Nature. 1988 Jul 21;334(6179):258-60 PMID: 2456467
  145. Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus.
    J Virol. 1993 Jan;67(1):613-6 PMID: 7677961
  146. Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells.
    Cell. 1989 Jul 28;58(2):293-303 PMID: 2568889
  147. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein.
    J Immunol. 1991 Mar 1;146(5):1560-5 PMID: 1704397
  148. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry.
    Science. 1992 Mar 6;255(5049):1261-3 PMID: 1546328
  149. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.
    J Immunol. 1994 Jan 1;152(1):163-75 PMID: 8254189
  150. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.
    J Exp Med. 1988 Aug 1;168(2):559-70 PMID: 2457647
  151. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
    J Immunol. 1994 Apr 15;152(8):3904-12 PMID: 7511661
  152. Cellular peptide composition governed by major histocompatibility complex class I molecules.
    Nature. 1990 Nov 15;348(6298):248-51 PMID: 2234092
  153. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8.
    J Immunol. 1994 Jan 15;152(2):620-31 PMID: 7506728
  154. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein.
    J Immunol. 1990 Jul 1;145(1):127-35 PMID: 1694201
  155. MHC class I H-2Kd-restricted antigenic peptides: additional constraints for the binding motif.
    Int Immunol. 1993 Nov;5(11):1489-92 PMID: 7505110
  156. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation.
    Science. 1992 Mar 6;255(5049):1264-6 PMID: 1546329
  157. Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein.
    J Virol. 1993 Dec;67(12):7041-9 PMID: 7693965
  158. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.
    Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2283-7 PMID: 1848698
  159. Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes.
    J Virol. 1992 May;66(5):3151-4 PMID: 1373204
  160. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.
    J Virol. 1994 May;68(5):3334-42 PMID: 7512163
  161. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries.
    J Exp Med. 1992 Oct 1;176(4):1007-13 PMID: 1402647
  162. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Nature. 1992 Aug 27;358(6389):764-8 PMID: 1380674
  163. HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.
    J Immunol. 1994 Jun 15;152(12):5742-8 PMID: 8207204
  164. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide.
    Eur J Immunol. 1992 Sep;22(9):2283-8 PMID: 1381312
  165. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
    J Immunol. 1993 Nov 1;151(9):4732-42 PMID: 8409432
  166. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.
    Science. 1994 Apr 29;264(5159):716-9 PMID: 7513441
  167. Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule.
    J Immunol. 1992 Jul 1;149(1):214-21 PMID: 1607654
  168. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes.
    Nature. 1991 Oct 31;353(6347):852-5 PMID: 1719425
  169. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
    J Exp Med. 1994 Sep 1;180(3):933-43 PMID: 7520476
  170. H-2Dd exploits a four residue peptide binding motif.
    J Exp Med. 1993 Dec 1;178(6):1877-92 PMID: 8245770
  171. Molecular analysis of the association of HLA-B53 and resistance to severe malaria.
    Nature. 1992 Dec 3;360(6403):434-9 PMID: 1280333
  172. Assembly and intracellular transport of MHC class I molecules.
    Annu Rev Cell Biol. 1993;9:207-35 PMID: 8280460
  173. Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes.
    J Exp Med. 1987 Jun 1;165(6):1508-23 PMID: 2438367
  174. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    J Immunol. 1994 May 15;152(10):4852-60 PMID: 8176208
  175. Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
    Int Immunol. 1990;2(4):311-6 PMID: 2126195
  176. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
    J Exp Med. 1994 Jul 1;180(1):347-52 PMID: 7516411
  177. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.
    J Immunol. 1994 Jan 1;152(1):106-16 PMID: 8254184
  178. Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90).
    Science. 1994 Jan 21;263(5145):384-7 PMID: 8278813
  179. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.
    J Clin Invest. 1990 Apr;85(4):1315-9 PMID: 2318983
  180. Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7380-3 PMID: 1323833
  181. Nomenclature for factors of the HLA system, 1994.
    Tissue Antigens. 1994 Jul;44(1):1-18 PMID: 7974464
  182. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein.
    Cell. 1992 Jun 12;69(6):989-98 PMID: 1606619
  183. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2.
    Cell. 1993 Nov 19;75(4):693-708 PMID: 7694806
  184. Characterization of peptide binding to the murine MHC class I H-2Kk molecule. Sequencing of the bound peptides and direct binding of synthetic peptides to isolated class I molecules.
    J Immunol. 1994 Oct 1;153(7):3079-92 PMID: 7522249
  185. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
    J Exp Med. 1990 Jan 1;171(1):345-9 PMID: 1688611
  186. Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides.
    J Immunol. 1994 Nov 1;153(9):4134-41 PMID: 7930617
  187. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.
    Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2105-9 PMID: 7510885
  188. Assembly, transport, and function of MHC class II molecules.
    Annu Rev Immunol. 1994;12:259-93 PMID: 8011283
  189. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.
    Cell. 1989 Nov 17;59(4):603-14 PMID: 2555063
  190. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma.
    Nature. 1994 May 5;369(6475):67-71 PMID: 8164742
  191. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules.
    Cell. 1993 Sep 10;74(5):929-37 PMID: 8104103
  192. Atomic structure of a human MHC molecule presenting an influenza virus peptide.
    Nature. 1992 Nov 26;360(6402):367-9 PMID: 1448154
  193. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
    Nature. 1992 Dec 3;360(6403):474-7 PMID: 1448172
  194. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis.
    Int Immunol. 1993 Oct;5(10):1229-37 PMID: 8268130
  195. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling.
    J Immunol. 1993 Sep 1;151(5):2572-87 PMID: 8360479
  196. MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding.
    Nature. 1994 Apr 28;368(6474):864-7 PMID: 8159247
  197. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
    J Exp Med. 1993 Sep 1;178(3):879-87 PMID: 7688791
  198. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy.
    Cancer Res. 1994 Jun 15;54(12):3124-6 PMID: 8205528
  199. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope.
    J Gen Virol. 1993 Nov;74 ( Pt 11):2357-63 PMID: 7504072
  200. Analysis of a naturally occurring HLA class I-restricted viral epitope.
    Immunology. 1994 Jul;82(3):337-42 PMID: 7525458
  201. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes.
    J Exp Med. 1990 Mar 1;171(3):763-73 PMID: 1689762
  202. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.
    Nature. 1994 Mar 17;368(6468):215-21 PMID: 8145819
  203. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
    J Immunol. 1994 Mar 1;152(5):2279-88 PMID: 8133041
  204. Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.
    J Virol. 1993 Jul;67(7):4086-92 PMID: 7685408
  205. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103).
    J Immunol. 1994 Apr 15;152(8):3946-57 PMID: 7511662
  206. Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones.
    Virology. 1993 Jul;195(1):62-70 PMID: 7686314
  207. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.
    Nature. 1993 Jan 28;361(6410):359-62 PMID: 7678924
  208. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.
    Nature. 1991 May 23;351(6324):290-6 PMID: 1709722
  209. Peptides naturally presented by MHC class I molecules.
    Annu Rev Immunol. 1993;11:213-44 PMID: 8476560
  210. An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide.
    J Gen Virol. 1993 Dec;74 ( Pt 12):2579-86 PMID: 8277264
  211. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.
    Proc Natl Acad Sci U S A. 1988 May;85(9):3105-9 PMID: 2452443
  212. Vaccination to prevent persistent viral infection.
    J Virol. 1993 Jul;67(7):4372-8 PMID: 8510226
  213. Comparison of the H-2Kk- and H-2Kkm1-restricted peptide motifs.
    J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):144-9 PMID: 8280703
  214. Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant.
    Int Immunol. 1992 Oct;4(10):1085-90 PMID: 1283332
  215. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.
    Arthritis Rheum. 1987 Nov;30(11):1205-13 PMID: 2446635
  216. A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone.
    Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11272-6 PMID: 8248240
  217. HIV-specific CD8+ T-cell immune responses and viral replication.
    AIDS. 1993 Nov;7 Suppl 2:S81-5 PMID: 7909230
  218. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.
    Nature. 1992 Oct 1;359(6394):429-31 PMID: 1328884
  219. Peptide selection by MHC class I molecules.
    Nature. 1991 Apr 25;350(6320):703-6 PMID: 1708852
  220. Defining rules for the peptide-MHC class II interaction.
    Curr Opin Immunol. 1994 Feb;6(1):52-6 PMID: 7513526
  221. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides.
    Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1508-12 PMID: 7679507
  222. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope.
    Virology. 1990 Oct;178(2):393-400 PMID: 1699348
Article Info
Journal
Immunogenetics
Abbr.
Immunogenetics
ISSN
0093-7711
DOI
10.1007/BF00172063
Published
1995-00-00
Pages
178-228
Language
English
Region
United States
NLM ID
0420404
Subset
IM
External Links
PubMed source DOI: 10.1007/BF00172063 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2